Table IV.

Caveats associated with the process of approval and administration and possible areas of improvement

Delay and reasons	Possible remedy
Delay in approval and reasons
Copayment	Determine copayment details during the time of prescription by a designated prior authorization team
Need for appeal because of inadequate information	Assign a designated prior authorization team that provides a prior authorization form along with the clinical notes up front
Delay in administration and reasons
Involvement of specialty pharmacies	1. Streamline the process at specialty pharmacies 2. Consider a buy and bill option
Unavailability of the patients for phone calls from the specialty pharmacy	Ensure patient education about the biologic approval process, and encourage patient engagement and participation